Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 27, 2025 | (Q2)Jun 28, 2025 | (Q1)Mar 29, 2025 | (FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.62%248.62M | 9.75%239.61M | -3.08%268.44M | -11.21%959.22M | -0.88%235.04M | -11.87%228.88M | -14.16%218.32M | -15.86%276.97M | 0.99%1.08B | -5.28%237.13M |
| Operating revenue | 8.62%248.62M | 9.75%239.61M | -3.08%268.44M | -11.21%959.22M | -0.88%235.04M | -11.87%228.88M | -14.16%218.32M | -15.86%276.97M | 0.99%1.08B | -5.28%237.13M |
| Cost of revenue | 12.08%202.34M | 12.34%186.29M | -3.11%204.94M | -13.89%741.95M | -2.33%184.07M | -14.05%180.54M | -18.06%165.82M | -18.88%211.52M | 2.60%861.65M | -3.60%188.47M |
| Gross profit | -4.28%46.28M | 1.56%53.33M | -2.99%63.5M | -0.65%217.27M | 4.74%50.97M | -2.61%48.35M | 1.00%52.51M | -4.31%65.46M | -4.89%218.69M | -11.27%48.66M |
| Operating expense | 11.66%36.8M | 0.61%36.46M | 0.82%38.99M | -4.02%145.25M | 5.75%37.38M | -4.65%32.96M | -0.17%36.24M | -14.28%38.67M | -0.89%151.33M | -2.73%35.35M |
| Selling and administrative expenses | 11.66%36.8M | 0.61%36.46M | 0.82%38.99M | -4.02%145.25M | 5.75%37.38M | -4.65%32.96M | -0.17%36.24M | -14.28%38.67M | -0.89%151.33M | -2.73%35.35M |
| -Selling and marketing expense | 8.25%12.06M | 9.05%11.44M | 1.74%12.49M | -20.48%45.23M | -3.04%11.33M | -19.66%11.14M | -25.39%10.49M | -28.95%12.28M | -4.67%56.88M | -14.99%11.68M |
| -General and administrative expense | 13.40%24.75M | -2.82%25.03M | 0.39%26.5M | 5.90%100.03M | 10.09%26.06M | 5.39%21.82M | 15.75%25.75M | -5.17%26.39M | 1.54%94.46M | 4.72%23.67M |
| Operating profit | -38.43%9.47M | 3.68%16.86M | -8.48%24.51M | 6.92%72.02M | 2.07%13.58M | 2.06%15.39M | 3.73%16.26M | 14.98%26.79M | -12.80%67.36M | -28.05%13.31M |
| Net non-operating interest income (expenses) | -178.15%-6.25M | -11.63%-5.71M | 20.49%-4.7M | 17.85%-21.51M | -217.27%-18.48M | 222.99%8M | 24.94%-5.12M | 16.04%-5.91M | -43.25%-26.19M | 2.43%-5.82M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | --8M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --6.25M | 11.63%5.71M | -20.49%4.7M | -18.76%20.06M | 293.44%17.02M | ---- | -24.94%5.12M | -16.04%5.91M | 45.12%24.69M | -7.98%4.33M |
| Total other finance cost | ---- | ---- | ---- | -2.87%1.45M | ---- | ---- | ---- | ---- | 18.15%1.5M | ---- |
| Other net income (expenses) | 232.33%307K | -118.66%-1.81M | 82.23%-123K | 404.71%21.52M | 3,266.75%12.76M | 77.78%-232K | 351.60%9.68M | 60.84%-692K | -202.97%-7.06M | 63.06%-403K |
| Gain on sale of security | ---- | ---- | ---- | 3,614.29%260K | ---- | ---- | ---- | ---- | -61.11%7K | ---- |
| Special income (charges) | 232.33%307K | -118.66%-1.81M | 82.23%-123K | 400.74%21.26M | 3,149.27%12.5M | 77.78%-232K | 351.60%9.68M | 60.84%-692K | -203.35%-7.07M | 63.03%-410K |
| -Less:Restructuring and mergern&acquisition | -232.33%-307K | 118.66%1.81M | -82.23%123K | -220.62%-8.53M | -43.41%232K | -77.78%232K | -351.60%-9.68M | -60.84%692K | 198.56%7.07M | -56.61%410K |
| -Less:Other special charges | ---- | ---- | ---- | ---12.73M | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -84.75%3.53M | -55.14%9.35M | -2.43%19.69M | 111.17%72.03M | 11.10%7.87M | 207.45%23.15M | 315.41%20.83M | 39.32%20.18M | -48.18%34.11M | -38.08%7.08M |
| Income tax | -125.75%-1.24M | -43.26%875K | 22.70%4.39M | 387.55%11.87M | 191.29%1.94M | 135.03%4.8M | 276.83%1.54M | 500.84%3.58M | -78.06%2.43M | 116.94%666K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -74.02%4.77M | -56.09%8.47M | -7.85%15.3M | 89.93%60.16M | -7.61%5.93M | 234.43%18.35M | 227.69%19.29M | 19.51%16.6M | -42.12%31.68M | -42.36%6.42M |
| Net income continuous operations | -74.02%4.77M | -56.09%8.47M | -7.85%15.3M | 89.93%60.16M | -7.61%5.93M | 234.43%18.35M | 227.69%19.29M | 19.51%16.6M | -42.12%31.68M | -42.36%6.42M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -74.02%4.77M | -56.09%8.47M | -7.85%15.3M | 89.93%60.16M | -7.61%5.93M | 234.43%18.35M | 227.69%19.29M | 19.51%16.6M | -42.12%31.68M | -42.36%6.42M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -74.02%4.77M | -56.09%8.47M | -7.85%15.3M | 89.93%60.16M | -7.61%5.93M | 234.43%18.35M | 227.69%19.29M | 19.51%16.6M | -42.12%31.68M | -42.36%6.42M |
| Diluted earnings per share | -73.77%0.16 | -52.54%0.28 | 4.08%0.51 | 101.06%1.89 | 5.26%0.2 | 281.25%0.61 | 227.78%0.59 | 19.51%0.49 | -41.98%0.94 | -42.42%0.19 |
| Basic earnings per share | -73.77%0.16 | -52.54%0.28 | 4.08%0.51 | 103.23%1.89 | 5.26%0.2 | 281.25%0.61 | 247.06%0.59 | 22.50%0.49 | -40.38%0.93 | -40.63%0.19 |
| Dividend per share | 11.20%0.1236 | 12.86%0.1237 | 6.54%0.1177 | 13.77%0.4525 | 9.89%0.1213 | 15.74%0.1112 | 14.68%0.1096 | 15.37%0.1105 | 20.72%0.3977 | 15.34%0.1104 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.